More recently, anti-TNF therapy by infliximab or etanercept treatment in combination with gemcitabine or paclitaxel chemotherapy was investigated using an orthotopic pancreatic cancer patient-derived xenograft mouse model and was found to be effective in delaying tumour growth and improving survival [39]. Here, TNF is linked to pancreatic neoplasm.